DAWN – Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, IncDAWN
$6.84Name : Day One Biopharmaceuticals, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $693,261,376.00
EPSttm : -1.02
Day One Biopharmaceuticals, Inc
$6.84
1.18%$0.08Float Short %
23.53
Margin Of Safety %
Put/Call OI Ratio
0.36
EPS Next Q Diff
0.29
EPS Last/This Y
-0.4
EPS This/Next Y
0.65
Price
6.84
Target Price
30.75
Analyst Recom
1.22
Performance Q
-44.84
Relative Volume
1.03
Beta
-1.1
Ticker: DAWN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-21 | DAWN | 8.24 | 0.45 | 4.12 | 8698 |
| 2025-03-24 | DAWN | 8.3 | 0.55 | 2.46 | 6895 |
| 2025-03-25 | DAWN | 8.21 | 0.56 | 0.01 | 6940 |
| 2025-03-26 | DAWN | 8.12 | 0.54 | 0.00 | 7101 |
| 2025-03-27 | DAWN | 8.19 | 0.54 | 0.00 | 7101 |
| 2025-03-28 | DAWN | 8.08 | 0.54 | 0.00 | 7090 |
| 2025-03-31 | DAWN | 7.94 | 0.54 | 1.07 | 7094 |
| 2025-04-01 | DAWN | 7.61 | 0.52 | 1.76 | 7107 |
| 2025-04-02 | DAWN | 7.98 | 0.51 | 1.65 | 7087 |
| 2025-04-03 | DAWN | 7.72 | 0.51 | 3.91 | 7212 |
| 2025-04-04 | DAWN | 7.23 | 0.51 | 17.00 | 7224 |
| 2025-04-07 | DAWN | 7.03 | 0.51 | 4.22 | 7230 |
| 2025-04-08 | DAWN | 6.66 | 0.46 | 0.32 | 6983 |
| 2025-04-09 | DAWN | 7.26 | 0.46 | 1.90 | 6978 |
| 2025-04-10 | DAWN | 6.75 | 0.46 | 0.41 | 6982 |
| 2025-04-11 | DAWN | 7.11 | 0.46 | 0.41 | 6982 |
| 2025-04-14 | DAWN | 7.21 | 0.45 | 1.25 | 7007 |
| 2025-04-15 | DAWN | 7.2 | 0.46 | 0.55 | 7025 |
| 2025-04-16 | DAWN | 6.76 | 0.44 | 999.99 | 7149 |
| 2025-04-17 | DAWN | 6.84 | 0.36 | 0.00 | 6734 |
| 2025-04-18 | DAWN | 6.84 | 0.36 | 0.00 | 6734 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-21 | DAWN | 8.23 | 42.2 | - | -1.40 |
| 2025-03-24 | DAWN | 8.31 | 42.2 | - | -1.40 |
| 2025-03-25 | DAWN | 8.28 | 42.2 | - | -1.40 |
| 2025-03-26 | DAWN | 8.12 | 42.2 | - | -1.40 |
| 2025-03-27 | DAWN | 8.18 | 42.2 | - | -1.40 |
| 2025-03-28 | DAWN | 8.07 | 42.2 | - | -1.40 |
| 2025-03-31 | DAWN | 7.94 | 42.2 | - | -1.40 |
| 2025-04-01 | DAWN | 7.61 | 42.2 | - | -1.40 |
| 2025-04-02 | DAWN | 7.97 | 42.2 | - | -1.40 |
| 2025-04-03 | DAWN | 7.72 | 42.2 | - | -1.40 |
| 2025-04-04 | DAWN | 7.22 | 42.2 | - | -1.40 |
| 2025-04-07 | DAWN | 7.02 | 42.2 | - | -1.42 |
| 2025-04-08 | DAWN | 6.71 | 40.4 | - | -1.42 |
| 2025-04-09 | DAWN | 7.26 | 40.4 | - | -1.42 |
| 2025-04-10 | DAWN | 6.75 | 40.4 | - | -1.42 |
| 2025-04-11 | DAWN | 7.11 | 40.4 | - | -1.42 |
| 2025-04-14 | DAWN | 7.22 | 40.4 | - | -1.42 |
| 2025-04-15 | DAWN | 7.19 | 40.4 | - | -1.42 |
| 2025-04-16 | DAWN | 6.77 | 40.4 | - | -1.42 |
| 2025-04-17 | DAWN | 6.84 | 40.4 | - | -1.42 |
| 2025-04-18 | DAWN | 6.84 | 40.4 | - | -1.42 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-21 | DAWN | -0.40 | 2.29 | 24.47 |
| 2025-03-24 | DAWN | -0.40 | 2.29 | 24.47 |
| 2025-03-25 | DAWN | -0.40 | 2.29 | 24.47 |
| 2025-03-26 | DAWN | -0.40 | 2.29 | 22.92 |
| 2025-03-27 | DAWN | -0.40 | 2.29 | 22.92 |
| 2025-03-28 | DAWN | -0.40 | 2.29 | 22.92 |
| 2025-03-31 | DAWN | -0.40 | 2.21 | 22.92 |
| 2025-04-01 | DAWN | -0.40 | 2.21 | 22.92 |
| 2025-04-02 | DAWN | -0.40 | 2.21 | 22.92 |
| 2025-04-03 | DAWN | -0.40 | 2.21 | 22.92 |
| 2025-04-04 | DAWN | -0.40 | 2.21 | 22.92 |
| 2025-04-07 | DAWN | -0.40 | 2.21 | 22.92 |
| 2025-04-08 | DAWN | -0.40 | 2.21 | 22.92 |
| 2025-04-09 | DAWN | -0.40 | 2.21 | 22.92 |
| 2025-04-10 | DAWN | -0.40 | 2.21 | 23.53 |
| 2025-04-11 | DAWN | -0.40 | 2.21 | 23.53 |
| 2025-04-14 | DAWN | -0.40 | 2.09 | 23.53 |
| 2025-04-15 | DAWN | -0.40 | 2.09 | 23.53 |
| 2025-04-16 | DAWN | -0.40 | 2.09 | 23.53 |
| 2025-04-17 | DAWN | -0.40 | 2.09 | 23.53 |
| 2025-04-18 | DAWN | -0.40 | 2.09 | 23.53 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.69
Avg. EPS Est. Current Quarter
-0.42
Avg. EPS Est. Next Quarter
-0.4
Insider Transactions
-0.4
Institutional Transactions
2.09
Beta
-1.1
Average Sales Estimate Current Quarter
31
Average Sales Estimate Next Quarter
37
Fair Value
Quality Score
44
Growth Score
26
Sentiment Score
60
Actual DrawDown %
76.2
Max Drawdown 5-Year %
Target Price
30.75
P/E
Forward P/E
PEG
P/S
5.29
P/B
1.38
P/Free Cash Flow
EPS
-1.04
Average EPS Est. Cur. Y
-1.42
EPS Next Y. (Est.)
-0.77
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-72.81
Relative Volume
1.03
Return on Equity vs Sector %
-39
Return on Equity vs Industry %
-25.6
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.02
EBIT Estimation
Day One Biopharmaceuticals, IncSector: Healthcare
Industry: Biotechnology
Employees: 181
Day One Biopharmaceuticals, Inc., a commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States. The company's lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed or refractory low-grade glioma; and Ipsen, a frontline raf-altered pLGG which is in Phase III clinical trial stage. It also developing DAY301, which is in phase I clinical trial for adult and pediatric cancers; and VRK1 Inhibitor which is in pre-clinical stage for adult and pediatric cancers. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.
stock quote shares DAWN – Day One Biopharmaceuticals, Inc. Stock Price stock today
news today DAWN – Day One Biopharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DAWN – Day One Biopharmaceuticals, Inc. yahoo finance google finance
stock history DAWN – Day One Biopharmaceuticals, Inc. invest stock market
stock prices DAWN premarket after hours
ticker DAWN fair value insiders trading